PERP B Stock Overview
Provides products and solutions for use of injectable drugs in Sweden.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Perpetua Medical AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | SEK 4.75 |
52 Week High | SEK 5.41 |
52 Week Low | SEK 0.49 |
Beta | 2.12 |
11 Month Change | 6.74% |
3 Month Change | 40.87% |
1 Year Change | 415.41% |
33 Year Change | -97.89% |
5 Year Change | -97.97% |
Change since IPO | -98.90% |
Recent News & Updates
Recent updates
Shareholder Returns
PERP B | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | 6.7% | -4.8% | -1.4% |
1Y | 415.4% | 5.6% | 20.7% |
Return vs Industry: PERP B exceeded the Swedish Medical Equipment industry which returned 10.2% over the past year.
Return vs Market: PERP B exceeded the Swedish Market which returned 25.9% over the past year.
Price Volatility
PERP B volatility | |
---|---|
PERP B Average Weekly Movement | 14.8% |
Medical Equipment Industry Average Movement | 7.2% |
Market Average Movement | 5.5% |
10% most volatile stocks in SE Market | 10.9% |
10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: PERP B's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: PERP B's weekly volatility has decreased from 22% to 15% over the past year, but is still higher than 75% of Swedish stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2007 | 4 | Anders Hedlund | perpetuamedical.se |
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. The company offers DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024.
Perpetua Medical AB (publ) Fundamentals Summary
PERP B fundamental statistics | |
---|---|
Market cap | SEK 21.48m |
Earnings (TTM) | -SEK 8.48m |
Revenue (TTM) | SEK 6.32m |
3.4x
P/S Ratio-2.5x
P/E RatioIs PERP B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PERP B income statement (TTM) | |
---|---|
Revenue | SEK 6.32m |
Cost of Revenue | SEK 3.06m |
Gross Profit | SEK 3.26m |
Other Expenses | SEK 11.74m |
Earnings | -SEK 8.48m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 22, 2024
Earnings per share (EPS) | -1.88 |
Gross Margin | 51.60% |
Net Profit Margin | -134.28% |
Debt/Equity Ratio | 0% |
How did PERP B perform over the long term?
See historical performance and comparison